Skip to main content
. 2011 Mar 10;22(12):2661–2666. doi: 10.1093/annonc/mdr011

Table 6.

Endothelial receptor levels in hemangioblastomas and RCCs (continued)

Receptor Tissue log(Hemangioblastoma)
log(RCC) P value (t-test) P value (Wilcoxon's rank sum test)
Mean SD
pVEGFR2 Endothelium 11.268 0.498 11.752 0.378 0.001 0.003
VEGFR total Endothelium 12.977 0.478 13.081 0.859 0.639 0.192
pPDGFR Endothelium 10.952 0.654 10.805 0.839 0.539 0.82
PDGFR total Endothelium 13.078 0.659 12.842 0.851 0.333 0.947
VEGFR ratio Endothelium 0.206 0.122 0.372 0.431 0.105 0.043
PDGFR ratio Endothelium 0.145 0.067 0.157 0.077 0.608 0.602
Tie2 Endothelium 12.654 0.455 12.63 0.817 0.909 0.883
Tie2 Whole tumor 11.598 0.321 11.614 0.303 0.866 0.947
FGFR3 Endothelium 12.265 0.448 12.29 0.961 0.914 0.495
FGFR3 Whole tumor 11.439 0.224 11.338 0.106 0.0075 0.174
pFRS2 Endothelium 12.495 0.492 11.91 0.989 0.023 0.059
pFRS2 Whole tumor 11.452 0.258 11.258 0.089 0.003 0.003

RCC, renal cell carcinoma; SD, standard deviation; pVEGFR, phosphorylated vascular endothelial growth factor receptor; VEGFR, vascular endothelial growth factor receptor; pPDGFR, phosphorylated platelet-derived growth factor receptor; PDGFR, platelet-derived growth factor receptor; FGFR3, fibroblast growth factor receptor-3; pFRS2, phosphorylated fibroblast growth factor receptor substrate-2.